Low dose androgenic compounds for prevention and treatment of endometriosis
US5753639A · kind A · utility
21Cited by
10References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 4, 1996 |
| Grant date | May 19, 1998 |
| Priority date | — |
| Expiry date | Jan 4, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/575
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treatment or prevention of breast and endometrial cancer, osteoporosis and endometriosis in susceptible warm-blooded animals comprising administering a low dose of a progestin or other steroid derivative having androgenic activity and low masculinizing activity. Pharmaceutical compositions useful for such treatment and pharmaceutical kits containing such compositions are disclosed. An in vitro assay permitting specific measurements of androgenic activity of potentially useful compounds is also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.